Skip to main content
SpringerLink
Log in

Modulation des Karotissinusnervs zur Therapie des Typ-2-Diabetes

Modulation of the carotid sinus nerve for treatment of type 2 diabetes

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Narkiewicz K, Ratcliffe LE, Hart EC, Briant LJ, Chrostowska M, Wolf J, Szyndler A, Hering D, Abdala AP, Manghat N, Burchell AE, Durant C, Lobo MD, Sobotka PA, Patel NK, Leiter JC, Engelman ZJ, Nightingale AK, Paton JF (2016) Unilateral carotid body resection in resistant hypertension: a safety and feasibility trial. JACC Basic Transl Sci 1(5):313–324

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sarr MG, Billington CJ, Brancatisano R, Brancatisano A, Toouli J, Kow L, Nguyen NT, Blackstone R, Maher JW, Shikora S, Reeds DN, Eagon JC, Wolfe BM, O’Rourke RW, Fujioka K, Takata M, Swain JM, Morton JM, Ikramuddin S, Schweitzer M, Chand B, Rosenthal R, EMPOWER Study Group. (2012) The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes Surg 22(11):1771–1782

    Article  PubMed  Google Scholar 

  3. Soin A, Shah NS, Fang ZP (2015) High-frequency electrical nerve block for postamputation pain: a pilot study. Neuromodulation 18(3):197–205 (discussion 205–6)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für klinische Diabetologie, Deutsches Diabetes-Zentrum, Leibniz-Zentrum für Diabetesforschung an der Heinrich-Heine-Universität, Auf’m Hennekamp 65, 40225, Düsseldorf, Deutschland

    S. Kahl

Authors
  1. S. Kahl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Kahl.

Ethics declarations

Interessenkonflikt

S. Kahl gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kahl, S. Modulation des Karotissinusnervs zur Therapie des Typ-2-Diabetes. Diabetologe 14, 110–112 (2018). https://doi.org/10.1007/s11428-018-0306-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-018-0306-2

Search

Navigation